Literature DB >> 19455057

TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma.

Matthew L Stoll1, Daniel H Solomon, Kerri L Batra, Julia F Simard, Elizabeth W Karlson, Paul F Dellaripa, Michael E Weinblatt, Roberta Glass, Nancy A Shadick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19455057      PMCID： PMC2954771          DOI： 10.1097/RHU.0b013e3181a7ace9

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  8 in total

1.  In search of childhood asthma: questionnaire, tests of bronchial hyperresponsiveness, and clinical evaluation.

Authors:  S T Remes; J Pekkanen; K Remes; R O Salonen; M Korppi
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

2.  Asthma as a risk factor for COPD in a longitudinal study.

Authors:  Graciela E Silva; Duane L Sherrill; Stefano Guerra; Robert A Barbee
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

3.  An undetected burden of asthma in Italy: the relationship between clinical and epidemiological diagnosis of asthma.

Authors:  R de Marco; I Cerveri; M Bugiani; M Ferrari; G Verlato
Journal:  Eur Respir J       Date:  1998-03       Impact factor: 16.671

4.  Steroid-unresponsive asthma.

Authors:  Donald Y M Leung; Joseph D Spahn; Stanley J Szefler
Journal:  Semin Respir Crit Care Med       Date:  2002-08       Impact factor: 3.119

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma.

Authors:  P H Howarth; K S Babu; H S Arshad; L Lau; M Buckley; W McConnell; P Beckett; M Al Ali; A Chauhan; S J Wilson; A Reynolds; D E Davies; S T Holgate
Journal:  Thorax       Date:  2005-09-15       Impact factor: 9.139

7.  The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma.

Authors:  Edward M Erin; Brian R Leaker; Grant C Nicholson; Andrew J Tan; Linda M Green; Helen Neighbour; Angela S Zacharasiewicz; Jackie Turner; Elliot S Barnathan; Onn Min Kon; Peter J Barnes; Trevor T Hansel
Journal:  Am J Respir Crit Care Med       Date:  2006-07-13       Impact factor: 21.405

8.  Evidence of a role of tumor necrosis factor alpha in refractory asthma.

Authors:  Mike A Berry; Beverley Hargadon; Maria Shelley; Debbie Parker; Dominick E Shaw; Ruth H Green; Peter Bradding; Christopher E Brightling; Andrew J Wardlaw; Ian D Pavord
Journal:  N Engl J Med       Date:  2006-02-16       Impact factor: 91.245
  8 in total
  2 in total

Review 1.  Stratified approaches to the treatment of asthma.

Authors:  Stephen T Holgate
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

Review 2.  Patient perspectives on fluticasone-vilanterol versus other corticosteroid combination products for the treatment of asthma.

Authors:  Suzanne G Bollmeier; Theresa R Prosser
Journal:  Patient Prefer Adherence       Date:  2016-05-13       Impact factor: 2.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.